Economy, business, innovation

Markets

BIO-key International, Inc. (BKYI) Q4 2025 Earnings: Key Takeaways

BKYI|EPS -$0.19|Rev $1.2M|Net Loss $1.7M Stock $0.53 (-11.5%) EPS YoY +58.7%|Rev YoY -15.1%|Net Margin -138.7% BIO-key International delivered a narrower quarterly loss but revenue deterioration accelerated, raising questions about near-term growth visibility despite management’s bullish Q1 outlook. The security technology firm posted a loss of $0.19 per share in Q4 2025, improving 58.7% from the […]

BIO-key International, Inc. (BKYI) Q4 2025 Earnings: Key Takeaways Read More »

CF Industries Holdings, Inc. (CF) Drops 6.2% to $128.95

CF Price $128.95 Change -6.2% Volume 4.4M CF Industries Holdings plunged 6.2% on Tuesday as a wave of insider selling totaling $53.2 million over the past month rattled investor confidence. The agricultural inputs company’s stock closed at $128.95 on heavy volume of 4.4 million shares, as investors digested substantial stock disposals by top executives including

CF Industries Holdings, Inc. (CF) Drops 6.2% to $128.95 Read More »

BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap

BKYI|EPS -$0.19|Rev $1.2M|Net Loss $1.7M Stock $0.51 (-13%) Losses Narrow Substantially. BIO-key International, Inc. (NASDAQ:BKYI) posted a loss per share of -$0.19 for Q4 2025, representing a 58.7% improvement from the -$0.46 loss recorded in the year-ago quarter. The security and protection services provider generated $1.2M in revenue for the period, down from $1.5M in

BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap Read More »

Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87

ARWR Price $61.87 Change +7.3% Volume 723,156 Arrowhead Pharmaceuticals surged 7.3% to $61.87 on Tuesday as a broad rally lifted biotechnology stocks across the sector. The $8.7 billion company rode a wave of bullish sentiment that pushed several sector peers sharply higher, with trading volume reaching 723,156 shares. The move was part of a coordinated

Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 Read More »

FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap

FDS|EPS $4.46|Rev $611.0M|Net Income $133.1M Guidance adjusted $17.25 – $17.75|Stock $290.37 (+2.3%) Solid Quarter Delivered. FactSet Research Systems Inc. (NYSE: FDS) reported Q2 2026 adjusted diluted earnings of $4.46 per share on revenue of $611.0M, representing a 7.1% increase from $570.7M in the prior-year period. The financial data and analytics provider posted bottom-line profit of

FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap Read More »

Reading International, Inc. (RDI) Reports Q4 Earnings

RDI|EPS -$0.11|Rev $50.3M|Net Loss $2.6M Reading International, Inc. (RDI) posted Q4 2025 Basic Loss per Share of -$0.11. Loss per share was down 10.0% from -$0.10 in Q4 2024. Revenue totaled $50.3M for the quarter. Revenue was down 14.0% year-over-year. Reading International, Inc. is a Entertainment company. Cinema Revenue was $46.9M for the quarter. Cinema

Reading International, Inc. (RDI) Reports Q4 Earnings Read More »

Scroll to Top